Provepharm
Lionel Fajolle possesses extensive experience in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Operating Officer at Provepharm Inc. since July 2024. Prior roles include Specialty Care Business Unit Head and Business Unit Head for Orthopaedics & Endocrinology at Ferring Pharmaceuticals from October 2018 to July 2024. Fajolle held various positions at Sanofi from November 2011 to October 2018, advancing from Director of Global Lyxumia Marketing to Associate Vice President of the US Diabetes Division. Early career experiences include roles at sanofi-aventis from 2002 to 2009, where Fajolle was a District Sales Manager and Senior Product Manager for AMBIEN CR. Fajolle holds an MBA in Marketing and Finance from ESSEC Business School and a Pharm D in Pharmaceutical Sciences from Université Paul Sabatier Toulouse III.
This person is not in any teams
This person is not in any offices
Provepharm
An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide and devotes between 20% and 25% of its revenues to R&D.